联系客服

300573 深市 兴齐眼药


首页 公告 兴齐眼药:上网7:公司2021年度财务决算报告

兴齐眼药:上网7:公司2021年度财务决算报告

公告日期:2022-04-20

兴齐眼药:上网7:公司2021年度财务决算报告 PDF查看PDF原文

                沈阳兴齐眼药股份有限公司

                  2021 年度财务决算报告

      公司 2021 年财务报表已经立信会计师事务所(特殊普通合伙)审计,并出
  具标准无保留意见的审计报告。结合公司 2021 年 12 月 31 日的财务状况、2021
  年度的经营成果、现金流量以及公司实际情况,我们进行了认真的研究分析,现
  将公司有关的财务决算情况汇报如下:

  一、2021 年度主要会计数据

                                                                                      单位:元

      项目一                      2021 年度        2020 年度      同比变动金额    同比变动%

      营业收入                1,027,914,866.71  688,682,125.80  339,232,740.91      49.26

      营业利润                  248,397,887.09  105,737,645.08  142,660,242.01      134.92

      利润总额                  243,542,286.83  102,541,715.12  141,000,571.71      137.51

      净利润                    209,107,825.26    93,460,207.73  115,647,617.53      123.74

      归属于母公司股东的净      194,702,374.35    87,978,613.68  106,723,760.67      121.31

  利润

      扣除非经常性损益后归      184,820,901.52    85,133,822.65    99,687,078.87      117.09

  属于上市公司股东的净利润

      项目二                    2021 年末余额    2020 年末余额    同比变动金额    同比变动%

      资产总额                1,686,844,280.72  965,701,210.74  721,143,069.98      74.68

      负债总额                  342,351,345.70  271,642,000.91    70,709,344.79      26.03

      所有者权益              1,344,492,935.02  694,059,209.83  650,433,725.19      93.71

      股本                      88,095,882.00    82,365,400.00    5,730,482.00        6.96

  (一)财务状况:

  1、资产结构

                                                                                      单位:元

        资产              2021 年        占资      2020 年      占资      同比变动      同比
                          年末余额      产%      年末余额      产%        金额        变动%

总资产                1,686,844,280.72  100.00  965,701,210.74  100.00  721,143,069.98    74.68

流动资产:              984,421,739.92  58.36  294,215,902.74  30.47  690,205,837.18  234.59

其中:货币资金          686,360,276.14  40.69  37,218,843.33    3.85  649,141,432.81  1744.12

      应收票据            18,944,161.31    1.12                            18,944,161.31

      应收账款          108,148,643.62    6.41  112,212,214.93  11.62  -4,063,571.31    -3.62

      应收款项融资        43,523,253.20    2.58  46,013,033.79    4.76  -2,489,780.59    -5.41


      预付款项            23,121,764.02    1.37  17,125,008.61    1.77    5,996,755.41    35.02

      其他应收款          5,844,780.06    0.35    3,147,200.38    0.33    2,697,579.68    85.71

      存货                92,330,953.24    5.47  68,309,552.30    7.07  24,021,400.94    35.17

      其他流动资产        6,147,908.33    0.36  10,190,049.40    1.06  -4,042,141.07  -39.67

非流动资产              702,422,540.80  41.64  671,485,308.00  69.53  30,937,232.80    4.61

其中:投资性房地产        12,262,029.58    0.73  10,402,342.80    1.08    1,859,686.78    17.88

      固定资产          499,971,088.95  29.64  505,583,248.87  52.35  -5,612,159.92    -1.11

      在建工程            34,941,776.10    2.07  22,312,142.44    2.31  12,629,633.66    56.60

      使用权资产          13,684,736.89    0.81                            13,684,736.89

      无形资产            22,833,782.93    1.35  23,828,688.54    2.47    -994,905.61    -4.18

      开发支出            51,014,956.71    3.02  21,604,841.50    2.24  29,410,115.21  136.13

      长期待摊费用        9,752,551.87    0.58    6,610,556.06    0.68    3,141,995.81    47.53

      递延所得税资产      30,446,339.14    1.80  33,872,735.63    3.51  -3,426,396.49  -10.12

      其他非流动资产      27,515,278.63    1.63  47,270,752.16    4.89  -19,755,473.53  -41.79

      流动资产比上年同期增加 690,205,837.18 元,增长幅度为 234.59%,其中
  变动比例超过 20%的指标分析如下:

      1)货币资金期末余额为 686,360,276.14 元,比上年同期增加

  649,141,432.81 元,增长幅度为 1744.12%,主要系定向增发取得募集资金所致;
      2)预付款项期末余额为 23,121,764.02 元,比上年同期增加 5,996,755.41
  元,增长幅度为 35.02%,主要系预付货款增加所致;

      3)其他应收款期末余额为 5,844,780.06 元,比上年同期增加 2,697,579.68
  元,增长幅度为 85.71%,主要系押金及保证金增加所致;

      4)存货期末余额为 92,330,953.24 元,比上年同期增加 24,021,400.94 元,
  增长幅度为 35.17%,主要系原材料及产成品增加所致;

      5)其他流动资产期末余额为 6,147,908.33 元,比上年同期减少

  4,042,141.07 元,减少幅度为 39.67%,主要系预缴企业所得税减少所致;

      非流动资产比上年同期增加 30,937,232.80 元,增长幅度为 4.61%。其中变
  动比例超过 20%的指标分析如下:

      1)在建工程期末余额为 34,941,776.10 元,比上年同期增加 12,629,633.66
  元,增长幅度为 56.60%,主要系报告期内扩大眼用制剂生产能力建设项目增加
  所致;

      2)开发支出期末余额为 51,014,956.71 元,比上年同期增加 29,410,115.21
  元,增长幅度为 136.13%,主要系药品三期临床费用投入增加所致;


    3)长期待摊费用期末余额为 9,752,551.87 元,比上年同期增加
 3,141,995.81 元,增长幅度为 47.53%,主要系装修改造费增加所致;

    4)其他非流动资产期末余额为 27,515,278.63 元,比上年同期减少

 19,755,473.53 元,减少幅度为 41.79%,主要系预付工程设备款减少所致;

    2、负债结构

                                                                                    单位:元

      负债          2021 年末余额  占负债%  2020 年末余额    占负    同比变动金额    同比
                                                                债%                    变动%

总负债              342,351,345.70    100.00  271,642,000.91  100.00  70,709,344.79    26.03

流动负债:          266,828,908.89    77.94  212,493,430.91  78.23  54,335,477.98    25.57

其中:短期借款      100,000,000.00    29.21  80,000,000.00  29.45  20,000,000.00    25.00

    应付账款      13,312,141.08      3.89    6,665,269.19    2.45    6,646
[点击查看PDF原文]